Pathogenic mechanisms in sepsis and septic shock;Mecanismos patogénicos en sepsis y choque séptico

Medicina Interna de Mexico

Volumn 24, Issue 1, 2008, Pages 38-42

  Rayo, Alfredo Cabrera ^a,b   Hernández, Guadalupe Laguna ^a   Huerta, Guadalupe López ^a   Ortiz, Asisclo Villagómez ^a   Reyes, Raquel Méndez ^a   Gómez, Ricardo Guzmán ^a  

^a ISSSTE

^b HOSPITAL REGIONAL 1 DE OCTUBRE   (Mexico)

Author keywords

Pathophysiology; Sepsis; Septic shock

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8;

BLOOD CLOTTING; CYTOKINE RELEASE; FIBRINOLYSIS; HUMAN; HYPOXIA; IMMUNE RESPONSE; INFLAMMATION; MORBIDITY; MORTALITY; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SEPSIS; SEPTIC SHOCK;

EID: 44349166387     PISSN: 01864866     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Bone RC, Fisher CJ Jr, Clemmer TP, et al. Sepsis syndrome: A valid clinical entity. Crit Care Med 1989;17:389-93.
2. Increase in national hospital discharge survey rates for septicemia-United States 1979-1987. Morbid Mortal Weekly Rep 1990;39:31-34.
3. Palencia E. Epidemiología de la sepsis. REMI 2004;4(7):C1. http://remi.uninet.edu/2004/07/REMICO1b.htm
4. González Chávez A, Conde Mercado JM. Epidemiología y etiología en sepsis y disfunción orgánica múltiple. En: Cuidados intensivos en el paciente séptico. México: Prado 2002;pp:1-18.
5. Balk RA, Bone RC. The septic syndrome: Definitions and clinical implications. Crit Care Clin 1989;5:1-8.
6. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002;360:219-23.
7. Fisher C, Dhainaut JF, Opal SM, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis síndrome. JAMA 1994;271:1835-43.
8. Zee KJ, De Foege LE, Fischer E, et al. IL-8 in septic shock, endotoxemia, and alter IL-1 administration. J Immunol 1991;146:3478-82.
9. Parrillo JE. Pathogenic mechanisms of septic shock. N Engl J Med 1993;328:1471-7.
10. Takeuchi O, Hocino K, Akira S. Cutting edge: TLR-2 deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Inmunol 2000;165:5392-6.